Foundry Partners LLC increased its stake in Medical Properties Trust, Inc. (NYSE:MPW) by 59.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 766,536 shares of the real estate investment trust’s stock after buying an additional 286,324 shares during the period. Foundry Partners LLC owned about 0.21% of Medical Properties Trust worth $9,865,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of MPW. UBS Asset Management Americas Inc. increased its stake in Medical Properties Trust by 13.6% in the fourth quarter. UBS Asset Management Americas Inc. now owns 458,798 shares of the real estate investment trust’s stock valued at $5,642,000 after buying an additional 54,835 shares during the last quarter. Macquarie Group Ltd. increased its stake in Medical Properties Trust by 3.9% in the fourth quarter. Macquarie Group Ltd. now owns 253,400 shares of the real estate investment trust’s stock valued at $3,116,000 after buying an additional 9,400 shares during the last quarter. Raymond James Trust N.A. bought a new stake in Medical Properties Trust during the first quarter valued at approximately $154,000. GW&K Investment Management LLC bought a new stake in Medical Properties Trust during the first quarter valued at approximately $148,000. Finally, Bank of Montreal Can increased its stake in Medical Properties Trust by 8.8% in the first quarter. Bank of Montreal Can now owns 44,122 shares of the real estate investment trust’s stock valued at $568,000 after buying an additional 3,573 shares during the last quarter. Institutional investors and hedge funds own 78.48% of the company’s stock.
Medical Properties Trust, Inc. (NYSE MPW) opened at 12.52 on Friday. The company’s 50-day moving average is $12.83 and its 200-day moving average is $13.04. Medical Properties Trust, Inc. has a 52-week low of $11.54 and a 52-week high of $15.74. The firm has a market capitalization of $4.38 billion, a P/E ratio of 15.31 and a beta of 0.89.
Medical Properties Trust (NYSE:MPW) last announced its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.32. The firm had revenue of $166.80 million during the quarter, compared to analysts’ expectations of $163.08 million. Medical Properties Trust had a return on equity of 7.54% and a net margin of 42.25%. The company’s revenue was up 32.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.32 earnings per share. On average, analysts predict that Medical Properties Trust, Inc. will post $0.88 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 14th. Stockholders of record on Thursday, June 15th were given a $0.24 dividend. The ex-dividend date of this dividend was Tuesday, June 13th. This represents a $0.96 annualized dividend and a dividend yield of 7.67%. Medical Properties Trust’s dividend payout ratio is 115.66%.
MPW has been the subject of several research reports. Royal Bank Of Canada reiterated a “buy” rating on shares of Medical Properties Trust in a research note on Monday, May 15th. ValuEngine downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Jefferies Group LLC reiterated a “buy” rating and set a $16.00 price objective (up from $15.00) on shares of Medical Properties Trust in a research note on Friday, June 9th. BidaskClub upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Saturday, June 10th. Finally, Deutsche Bank AG lifted their price objective on shares of Medical Properties Trust from $13.50 to $15.00 and gave the stock a “buy” rating in a research note on Tuesday, July 4th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $14.20.
In other news, CFO R Steven Hamner sold 85,000 shares of the stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.00% of the stock is currently owned by corporate insiders.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).
Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
